1. |
Garber A, Frakes C, Arora Z, et al. Mechanisms and management of acute pancreatitis. Gastroenterol Res Pract, 2018, 2018: 6218798.
|
2. |
van Santvoort HC, Bakker OJ, Bollen TL, et al. A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome. Gastroenterology, 2011, 141(4): 1254-1263.
|
3. |
Lu J, Xie Y, Du J, et al. Penta-therapy for severe acute hyperlipidemic pancreatitis. Am J Emerg Med, 2018, 36(10): 1789-1795.
|
4. |
Ge P, Luo Y, Okoye CS, et al. Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: a troublesome trio for acute pancreatitis. Biomed Pharmacother, 2020, 132: 110770.
|
5. |
Scherer J, Singh VP, Pitchumoni CS, et al. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol, 2014, 48(3): 195-203.
|
6. |
高甘油三酯血症性急性胰腺炎诊治急诊共识专家组. 高甘油三酯血症性急性胰腺炎诊治急诊专家共识. 中华急诊医学杂志, 2021, 30(8): 937-947.
|
7. |
Zheng CB, Zheng ZH, Zheng YP. Therapeutic plasma exchange for hyperlipidemic pancreatitis: current evidence and unmet needs. World J Clin Cases, 2021, 9(21): 5794-5803.
|
8. |
Uyar S, Harmandar F, Kok M, et al. Management of hypertriglyceridemia induced acute pancreatitis and therapeutic plasmapheresis: report of nine cases and review of literature. Acta Gastroenterol Belg, 2017, 80(1): 71-74.
|
9. |
Hofbauer B, Friess H, Weber A, et al. Hyperlipaemia intensifies the course of acute oedematous and acute necrotising pancreatitis in the rat. Gut, 1996, 38(5): 753-758.
|
10. |
马江辰, 保志军. 高脂血症性急性胰腺炎发病机制的研究进展. 国际消化病杂志, 2017, 37(1): 24-27.
|
11. |
Pothoulakis I, Paragomi P, Archibugi L, et al. Clinical features of hypertriglyceridemia-induced acute pancreatitis in an international, multicenter, prospective cohort (APPRENTICE consortium). Pancreatology, 2020, 20(3): 325-330.
|
12. |
Inoue NT, Hanafusa T, Hirohata A, et al. Eruptive xanthoma with acute pancreatitis in a patient with hypertriglyceridemia and diabetes. Ann Dermatol, 2016, 28(1): 136.
|
13. |
Fortson MR, Freedman SN, Webster PD 3rd. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol, 1995, 90(12): 2134-2139.
|
14. |
Vipperla K, Somerville C, Furlan A, et al. Clinical profile and natural course in a large cohort of patients with hypertriglyceridemia and pancreatitis. J Clin Gastroenterol, 2017, 51(1): 77-85.
|
15. |
Forsmark CE, Vege SS, Wilcox CM. Acute Pancreatitis. N Engl J Med, 2016, 375(20): 1972-1981.
|
16. |
Garg R, Rustagi T. Management of hypertriglyceridemia induced acute pancreatitis. Biomed Res Int, 2018, 2018: 4721357.
|
17. |
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut, 2013, 62(1): 102-111.
|
18. |
杜奕奇, 陈其奎, 李宏宇, 等. 中国急性胰腺炎诊治指南(2019 年, 沈阳). 临床肝胆病杂志, 2019, 35(12): 2706-2711.
|
19. |
Adiamah A, Psaltis E, Crook M, et al. A systematic review of the epidemiology, pathophysiology and current management of hyperlipidaemic pancreatitis. Clin Nutr, 2018, 37(6 Pt A): 1810-1822.
|
20. |
杨立新, 杜丽川, 刘欣, 等. 四种评分标准对高脂血症性急性胰腺炎病情和预后的评估作用. 中华内科杂志, 2016, 55(9): 695-699.
|
21. |
Jin M, Peng JM, Zhu HD, et al. Continuous intravenous infusion of insulin and heparin vs plasma exchange in hypertriglyceridemia-induced acute pancreatitis. J Dig Dis, 2018, 19(12): 766-772.
|
22. |
Jain P, Rai RR, Udawat H, et al. Insulin and heparin in treatment of hypertriglyceridemia-induced pancreatitis. World J Gastroenterol, 2007, 13(18): 2642-2643.
|
23. |
Jain D, Zimmerschied J. Heparin and insulin for hypertriglyceridemia-induced pancreatitis: case report. Sci World J, 2009, 9: 1230-1232.
|
24. |
韩叶叶. 高脂血症急性胰腺炎血液净化治疗的探究. 大连: 大连医科大学, 2018.
|
25. |
Yu S, Yao D, Liang X, et al. Effects of different triglyceride-lowering therapies in patients with hypertriglyceridemia-induced acute pancreatitis. Exp Ther Med, 2020, 19(4): 2427-2432.
|
26. |
Biberci KE, Koçhan K, Köker İH, et al. The role of plasma exchange in hypertriglyceridemia-induced acute pancreatitis. Eur J Gastroenterol Hepatol, 2019, 31(6): 674-677.
|
27. |
Betteridge DJ, Bakowski M, Taylor KG, et al. Treatment of severe diabetic hypertriglyceridaemia by plasma exchange. Lancet, 1978, 1(8078): 1368.
|
28. |
Click B, Ketchum AM, Turner R, et al. The role of apheresis in hypertriglyceridemia-induced acute pancreatitis: a systematic review. Pancreatology, 2015, 15(4): 313-320.
|
29. |
Ruiz-Rodríguez JC, Chiscano-Camón LS, Palmada C, et al. Plasmapheresis for the treatment of acute pancreatitis due to severe hypertriglyceridemia. Blood Purif, 2021, 50(4/5): 572-574.
|
30. |
Joury A, Alshehri M, Mahendra A, et al. Therapeutic approaches in hypertriglyceridemia-induced acute pancreatitis: a literature review of available therapies and case series. J Clin Apher, 2020, 35(2): 131-137.
|
31. |
Mao E. Intensive management of severe acute pancreatitis. Ann Transl Med, 2019, 7(22): 687.
|
32. |
张琪月, 朱如萍, 唐国都, 等. 血液净化治疗高脂血症性胰腺炎的研究进展. 国际消化病杂志, 2020, 40(2): 109-112, 118.
|
33. |
Kyriakidis AV, Raitsiou B, Sakagianni A, et al. Management of acute severe hyperlipidemic pancreatitis. Digestion, 2006, 73(4): 259-264.
|
34. |
Gubensek J, Buturovic-Ponikvar J, Romozi K, et al. Factors affecting outcome in acute hypertriglyceridemic pancreatitis treated with plasma exchange: an observational cohort study. PLoS One, 2014, 9(7): e102748.
|
35. |
Dehal H, Adashek M. Total plasma exchange in hypertriglyceridemia-induced pancreatitis: case report and literature review. Case Rep Med, 2018, 2018: 4017573.
|
36. |
Miyamoto K, Horibe M, Sanui M, et al. Plasmapheresis therapy has no triglyceride-lowering effect in patients with hypertriglyceridemic pancreatitis. Intensive Care Med, 2017, 43(6): 949-951.
|
37. |
He WH, Yu M, Zhu Y, et al. Emergent triglyceride-lowering therapy with early high-volume hemofiltration against low-molecular-weight heparin combined with insulin in hypertriglyceridemic pancreatitis: a prospective randomized controlled trial. J Clin Gastroenterol, 2016, 50(9): 772-778.
|
38. |
Winters JL, American Society for Apheresis. American Society for Apheresis guidelines on the use of apheresis in clinical practice: practical, concise, evidence-based recommendations for the apheresis practitioner. J Clin Apher, 2014, 29(4): 191-193.
|